David Shapiro, Chief Medical Officer at INTERCEPT PHARMACEUTICALS, INC. (ICPT), sold 474 shares at $97.48 ($46K) on 2019-01-04, disclosed to the SEC on 2019-01-04.
Scheduled sale ($46k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ICPT | SELL | 2019-04-03 | $129K | — | Filing → |
| ICPT | SELL | 2019-03-01 | $206K | — | Filing → |
| ICPT | SELL | 2019-02-20 | $223K | — | Filing → |